[1] CHEN S C, PERFECT J, COLOMBO A L, et al. Global guideline for the diagnosis and management of rare yeast infections: An initiative of the ECMM in cooperation with ISHAM and ASM[J]. Lancet Infect Dis, 2021, 21(12): e375-e386. [2] SPRUTE R, CORNELY O A, CHEN S C, et al. All you need to know and more about the diagnosis and management of rare yeast infections[J]. mBio, 2021, 12(4):e0159421. [3] ZHANG S X, BABADY N E, HANSON K E, et al. Recognition of diagnostic gaps for laboratory diagnosis of fungal diseases: expert opinion from the fungal diagnostics laboratories consortium (FDLC)[J]. J Clin Microbiol, 2021, 59(7): e0178420. [4] 陈东科,孙长贵. 实用临床微生物学检验与图谱[M]. 北京: 人民卫生出版社,2010,661-667 [5] NOSTER J, KOEPPEL M B, DESNOS-OLIVIER M, et al. Bloodstream infections caused by Magnusiomyces capitatus and Magnusiomyces clavatus: epidemiological, clinical, and microbiological features of two emerging yeast species[J]. Antimicrob Agents Chemother, 2022, 66(2): e0183421. [6] 徐春晖, 周密, 徐和平.译文:罕见酵母菌感染诊断和管理全球指南:ECMM与ISHAM和ASM合作的倡议[EB/OL].[2022-09-09]. http://www.360doc.com/content/22/0909/17/62644061_1047275177.shtml. [7] ITOH K, IWASAKI H, NEGORO E, et al. Successful treatment of breakthrough Trichosporon asahii fungemia by the combination therapy of fluconazole and liposomal amphotericin B in a patient with follicular lymphoma[J]. Mycopathologia, 2021, 186(1): 113-117. [8] LI H, GUO M, WANG C, et al. Epidemiological study of Trichosporon asahii infections over the past 23 years[J]. Epidemiol Infect, 2020, 148:e169. DOI: 10.1017/S095026882000.1624. [9] STANZANI M, CRICCA M, SASSI C, et al. Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: a report of a monocentric outbreak and review of the literature[J]. Mycoses, 2019, 62(12): 1100-1107. [10] BUCHTA V, BOLEHOVSKÁ R, HOVORKOVÁ E, et al. Saprochaete clavata invasive infections-a new threat to hematological-oncological patients[J]. Front Microbiol, 2019, 10: 2196.DOI: 10.389/fmicb.2019.02196. [11] LEONI M, RICCARDI N, ROTULO G A, et al. Magnusiomyces clavatus infection in a child after allogeneic hematotopoetic stem cell transplantation: diagnostic and therapeutic implications[J]. Med Mycol Case Rep, 2019, 23: 65-67.DOI: 10.1016/j.mmcr.2018.12.005. [12] GURRIERI F, CORBELLINI S, PICCINELLI G, et al. Management of invasive infections due to a rare arthroconidial yeast, Saprochaete Capitata, in two patients with acute hematological malignancies[J]. Vaccines (Basel), 2021, 9(11): 1289. [13] ZHANG D, LU X, LIAO Y, et al. Rapid and simple detection of Trichosporon asahii by optimized colony PCR[J]. Biomed Res Int, 2019,1803278.DOI:10.1155/2019/1803278. [14] WEBER J K, SCHARF S, WALTHER G, et al. Detection of invasive Trichosporon asahii in patient blood by a fungal PCR array[J]. Access Microbiol, 2021, 3(12): 000285. [15] KAPLAN E, AKTAŞ D, DÖĞEN A, et al. Development and analysis of qPCR for the identification of arthroconidial yeasts of the genus Magnusiomyces[J]. Mycopathologia, 2021, 186(1): 41-51. [16] FORSTER J, KOC Ö, KOEPPEL M B, et al. β-1,3-d-glucan and galactomannan as biomarkers for the detection of invasive Geotrichum and Magnusiomyces infections: a retrospective evaluation[J]. J Clin Microbiol, 2022, 60(1): e0160721. [17] HU B, TAO Y, SHAO Z, et al. A comparison of blood pathogen detection among droplet digital PCR, metagenomic next-generation sequencing, and blood culture in critically ill patients with suspected bloodstream infections[J]. Front Microbiol, 2021, 12: 641202.DOI: 10.3389/fmicb.641202. [18] GU W, DENG X, LEE M, et al. Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids[J]. Nat Med, 2021,27(1):115-124. |